Biomarkers in Heart Failure, An Issue of Heart Failure Clinics, 1st Edition
Author :
Eugene Braunwald
Biomarkers — which may be enzymes, hormones, biologic substances, or other markers of cardiac stress and malfunction — appear to have growing clinical importance in heart failure. Many biomarkers appear to provide important information about the
...view more
Biomarkers — which may be enzymes, hormones, biologic substances, or other markers of cardiac stress and malfunction — appear to have growing clinical importance in heart failure. Many biomarkers appear to provide important information about the cause of heart failure or the identification of those at risk for heart failure or appear to be useful in risk stratification, in the diagnosis of heart failure, or in monitoring therapy. This issue discusses the current and potential future role of biomarkers and includes articles that explore individual biomarkers in depth.
Biomarkers — which may be enzymes, hormones, biologic substances, or other markers of cardiac stress and malfunction — appear to have growing clinical importance in heart failure. Many biomarkers appear to provide important information about the cause of heart failure or the identification of those at risk for heart failure or appear to be useful in risk stratification, in the diagnosis of heart failure, or in monitoring therapy. This issue discusses the current and potential future role of biomarkers and includes articles that explore individual biomarkers in depth.
Author Information
By Eugene Braunwald, MD, Distinguished Hersey Professor of Medicine, Harvard Medical School; Chairman, TIMI Study Group, Brigham and Women's Hospital, Boston, MA
https://www.us.elsevierhealth.com/biomarkers-in-heart-failure-an-issue-of-heart-failure-clinics-9781437714463.html6158Biomarkers in Heart Failure, An Issue of Heart Failure Clinicshttps://www.us.elsevierhealth.com/media/catalog/product/9/7/9781437714463.jpg74.2498.99USDInStock/Medicine/Cardiology/ClinicsBiomarkers — which may be enzymes, hormones, biologic substances, or other markers of cardiac stress and malfunction — appear to have growing clinical importance in heart failure. Many biomarkers appear to provide important information about the cause of heart failure or the identification of those at risk for heart failure or appear to be useful in risk stratification, in the diagnosis of heart failure, or in monitoring therapy. This issue discusses the current and potential future role of biomarkers and includes articles that explore individual biomarkers in depth. Biomarkers — which may be enzymes, hormones, biologic substances, or other markers of cardiac stress and malfunction — appear to have growing clinical importance in heart failure. Many biomarkers appear to provide important information about the cause of heart failure or the identification of those at risk for heart failure or appear to be useful in risk stratification, in the diagnosis of heart failure, or in monitoring therapy. This issue discusses the current and potential future role of biomarkers and includes articles that explore individual biomarkers in depth.00add-to-cart97814377144632011 and earlierProfessionalBy Eugene Braunwald, MD20091BookSaunders02009-09-02 00:00:00IN STOCK - This may take up to 5 business days to shipBy <STRONG>Eugene Braunwald</STRONG>, MD, Distinguished Hersey Professor of Medicine, Harvard Medical School; Chairman, TIMI Study Group, Brigham and Women's Hospital, Boston, MAClinicsClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
